Related Experiment Video
Updated: May 18, 2026
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
Insights into LRRK2 function and dysfunction from transgenic and knockout rodent models
Maximilian Sloan1, Javier Alegre-Abarrategui, Richard Wade-Martins
1Oxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, U.K.
Abstract:
Mutations in the LRRK2 (leucine-rich repeat kinase 2) gene on chromosome 12 cause autosomal dominant PD (Parkinson's disease), which is indistinguishable from sporadic forms of the disease. Numerous attempts have therefore been made to model PD in rodents via the transgenic expression of LRRK2 and its mutant variants and to elucidate the function of LRRK2 by knocking out rodent Lrrk2. Although these models often only partially recapitulate PD pathology, they have helped to elucidate both the normal and pathological function of LRRK2. In particular, LRRK2 has been suggested to play roles in cytoskeletal dynamics, synaptic machinery, dopamine homoeostasis and autophagic processes. Our understanding of how these pathways are affected, their contribution towards PD development and their interaction with one another is still incomplete, however. The present review summarizes the findings from LRRK2 rodent models and draws potential connections between the apparently disparate cellular processes altered, in order to better understand the underlying mechanisms of LRRK2 dysfunction and illuminate future therapeutic interventions.
Insights
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are linked to Parkinson's disease (PD). LRRK2 rodent models, though imperfect, offer insights into LRRK2's role in PD pathogenesis and potential therapies.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a known cause of autosomal dominant Parkinson's disease (PD).
- LRRK2-linked PD is clinically indistinguishable from sporadic PD, highlighting the need for effective disease models.
- Understanding LRRK2's function is crucial for developing targeted therapies for Parkinson's disease.
Purpose of the Study:
- To review findings from LRRK2 rodent models in Parkinson's disease research.
- To elucidate the normal and pathological functions of LRRK2.
- To connect altered cellular processes and identify mechanisms of LRRK2 dysfunction for therapeutic development.
Main Methods:
- Review of studies utilizing transgenic LRRK2 expression in rodents.
- Analysis of data from Lrrk2 knockout rodent models.
- Synthesis of findings to identify common pathways affected by LRRK2.
Main Results:
- LRRK2 rodent models partially recapitulate PD pathology.
- LRRK2 is implicated in cytoskeletal dynamics, synaptic function, dopamine homeostasis, and autophagy.
- Disparate cellular processes altered by LRRK2 dysfunction are being identified.
Conclusions:
- LRRK2 rodent models are valuable tools for studying Parkinson's disease.
- Further research is needed to fully understand the contribution of LRRK2 pathways to PD.
- Insights from these models may lead to novel therapeutic strategies for Parkinson's disease.
